An Efficient Treatment for Posttraumatic Injury for Firefighters

Sponsor
Palo Alto Veterans Institute for Research (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05950035
Collaborator
University of Arizona (Other), Oregon State University (Other), Boston University (Other), The University of Texas Health Science Center at San Antonio (Other), National Development and Research Institutes, Inc. (Other)
50
1
2
10.1
5

Study Details

Study Description

Brief Summary

The goal of this two-arm pilot randomized controlled trial is to test a behavioral intervention that integrates three evidence-based cognitive behavioral interventions (written exposure therapy; WET, cognitive behavioral therapy for insomnia; CBT-I, and cognitive behavioral therapy for nightmares; CBT-N) among firefighters. The main questions it aims to answer are:

  • Is the behavioral intervention feasible, acceptable, and effective in reducing symptoms of posttraumatic stress, insomnia, and nightmares?

  • What is the efficacy of efficient treatment vs. delayed treatment (2-4 week waitlist) in reducing symptoms of posttraumatic stress, insomnia, and nightmares?

We will beta test the intervention in 1-2 groups of 3-5 firefighters. Then we will randomize 50 participants to immediate or delayed (2-4 week waitlist) treatment. Consented participants will:

  • Complete self-report and interview measures assessing posttraumatic stress disorder, insomnia (PTSD), and nightmares

  • Attend an individual treatment orientation session

  • Attend a 4-day (~3 hours per day over 4 consecutive days) group treatment that integrates WET, CBT-I, and CBT-N

  • Attend an individual booster session held approximately one week later

  • Complete self-report measures before, during, and after treatment, and at a 3-month follow up assessment and a clinical interview before and after treatment to assess program efficacy.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Written Exposure Therapy (WET)
  • Behavioral: Cognitive Behavioral Therapy for Insomnia (CBTi)
  • Behavioral: Cognitive Behavioral Therapy for Nightmares (CBTn)
  • Behavioral: Waitlist
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
An Efficient Treatment for Posttraumatic Injury for Firefighters
Anticipated Study Start Date :
Jul 18, 2023
Anticipated Primary Completion Date :
May 20, 2024
Anticipated Study Completion Date :
May 20, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Immediate Intervention

Will begin treatment within 2 weeks of randomization.

Behavioral: Written Exposure Therapy (WET)
WET is a trauma-focused intervention in which individuals write about their worst traumatic experience following scripted instruction from the therapist.

Behavioral: Cognitive Behavioral Therapy for Insomnia (CBTi)
CBTi focuses on stimulus control, eliminating maladaptive coping habits, reducing arousal, and challenging maladaptive thoughts about sleep in an effort to reduce time to fall asleep and time awake during the night.

Behavioral: Cognitive Behavioral Therapy for Nightmares (CBTn)
CBTn involves writing about a distressing or frequent nightmare, rewriting the narrative of the nightmare to target trauma-related themes, and reading the rescripted nightmare narrative.

Active Comparator: Delayed Intervention

Will be scheduled to begin treatment within 4-6 weeks of randomization.

Behavioral: Waitlist
Waitlist for delayed intervention.

Outcome Measures

Primary Outcome Measures

  1. Clinician Administered PTSD Scale (CAPS-5) [Change from baseline to post treatment (~4 weeks post baseline)]

    The CAPS-5 is a structured clinical interview that assesses the presence and severity of PTSD symptoms.

  2. Structured Clinical Interview for DSM-5 Sleep Disorders- Revised (SCISD-R) [Change from baseline to post treatment (~4 weeks post baseline)]

    The SCISD-R is a semi-structured interview designed to obtain a sleep history and screen for certain sleep disorders and diagnose others, including insomnia, hypersomnia, circadian rhythm sleep-wake disorders, sleep-disordered breathing, and parasomnias.

  3. Insomnia Severity Index (ISI) [Change from baseline through 3 months post treatment]

    The ISI assesses perceived severity of insomnia.

  4. Nightmare Disorders Index [Change from baseline through 3 months post treatment]

    The NDI is a self-report assessment of nightmare disorder.

  5. Posttraumatic Stress Disorder Checklist (PCL-5) [Change from baseline through 3 months post treatment]

    Self-report measure update of the PCL designed to assess PTSD symptoms as defined by the DSM-5.

Secondary Outcome Measures

  1. Trauma-Related Nightmare Survey (TRNS) [Change from baseline through 3 months post treatment]

    The TRNS assesses nightmare frequency, disturbance, and characteristics.

  2. Self-Assessment of Sleep (SASS) [Change from baseline through 3 months post treatment]

    The SASS is a brief assessment of self-reported sleep quantity and sleep quality.

  3. Sleep Diary and Nightmare Log [Change from baseline through post treatment (~4 weeks post baseline)]

    The Sleep Diary and Nightmare Log assess daily subjective sleep patterns and to inform treatment recommendations.

  4. Patient Health Questionnaire-9 (PHQ-9) [Change from baseline through 3 months post treatment]

    The PHQ-9 the severity of affective and somatic symptoms related to depression; items correspond to the diagnostic criteria for major depression disorder.

  5. Depressive Symptoms Index-Suicidality Subscale (DSI-SS) [Change from baseline through 3 months post treatment]

    The DSI-SS is a self-report measure of suicidal ideation, plans, perceived control over ideation, and impulses for suicide.

  6. Net Prompter Score [Post treatment (~4 weeks post baseline)]

    The Net Prompter Score is a single item measures of treatment acceptability that asks respondents to rate the likelihood that they would recommend the efficient treatment to a friend or colleague on a scale from 0-10.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18-65 years old

  • Firefighter

  • Able to speak and read English

  • Clinically significant posttraumatic stress symptoms: CAPS-5 total score ≥ 25; ≥ 1 intrusion symptom; ≥ 1 avoidance symptom

  • Clinically significant symptoms of insomnia: SCISD insomnia criteria are met; ISI ≥ 15

  • Clinically significant symptoms of nightmare disorder: SCISD nightmare disorder criteria are met, nightmares ≥ 1 monthly.

Exclusion Criteria:
  • Current suicide or homicide risk meriting crisis intervention

  • Inability to speak and read English

  • Inability to comprehend the baseline screening questionnaires

  • Unwilling to remain abstinent from alcohol during treatment

  • Serious mental health diagnosis such as bipolar disorder or psychosis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 NDRI_USA Kansas City Missouri United States 66224

Sponsors and Collaborators

  • Palo Alto Veterans Institute for Research
  • University of Arizona
  • Oregon State University
  • Boston University
  • The University of Texas Health Science Center at San Antonio
  • National Development and Research Institutes, Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Carmen McLean, Clinical Psychologist, Palo Alto Veterans Institute for Research
ClinicalTrials.gov Identifier:
NCT05950035
Other Study ID Numbers:
  • MCA0006AGG
First Posted:
Jul 18, 2023
Last Update Posted:
Jul 18, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2023